# CABERGOLINE
> **ANDA220309** · Abbreviated New Drug Application (Generic) · Sponsor: RENATA · Approved 2026-06-15
## Drug
- **FDA Application Number:** ANDA220309
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CABERGOLINE
- **Generic name:** CABERGOLINE
- **Active ingredients:** CABERGOLINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RENATA
- **Manufacturer:** Cranbury Pharmaceuticals, LLC
- **First approval:** 2026-06-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220309)
---
*MORVS · CC0 1.0*